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Abstract
Poliovirus IRES-mediated translation requires the functions of certain canonical as well as non-canonical factors for the
recruitment of ribosomes to the viral RNA. The interaction of cellular proteins PCBP2 and SRp20 in extracts from poliovirus-
infected cells has been previously described, and these two proteins were shown to function synergistically in viral
translation. To further define the mechanism of ribosome recruitment for the initiation of poliovirus IRES-dependent
translation, we focused on the role of the interaction between cellular proteins PCBP2 and SRp20. Work described here
demonstrates that SRp20 dramatically re-localizes from the nucleus to the cytoplasm of poliovirus-infected neuroblastoma
cells during the course of infection. Importantly, SRp20 partially co-localizes with PCBP2 in the cytoplasm of infected cells,
corroborating our previous in vitro interaction data. In addition, the data presented implicate the presence of these two
proteins in viral translation initiation complexes. We show that in extracts from poliovirus-infected cells, SRp20 is associated
with PCBP2 bound to poliovirus RNA, indicating that this interaction occurs on the viral RNA. Finally, we generated a
mutated version of SRp20 lacking the RNA recognition motif (SRp20DRRM) and found that this protein is localized similar to
the full length SRp20, and also partially co-localizes with PCBP2 during poliovirus infection. Expression of this mutated
version of SRp20 results in a ,100 fold decrease in virus yield for poliovirus when compared to expression of wild type
SRp20, possibly via a dominant negative effect. Taken together, these results are consistent with a model in which SRp20
interacts with PCBP2 bound to the viral RNA, and this interaction functions to recruit ribosomes to the viral RNA in a direct
or indirect manner, with the participation of additional protein-protein or protein-RNA interactions.
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Introduction
Translation of eukaryotic mRNAs most often occurs via a cap-
dependent mechanism of initiation (see Figure 1A). Cellular
mRNAs contain a 7-methyl guanosine cap at their 59 ends, and
this cap structure is recognized by the eukaryotic initiation factor
4F (eIF4F) cap binding complex. The eIF4F complex consists of
the initiation factors 4A, 4G, and 4E and recruits the ribosome to
the mRNA for translation initiation. The 40S ribosomal subunit
binds a protein complex that consists of eIF1, eIF2-GTP-Met-
tRNA (i.e., the ternary complex), eIF3, and eIF5. The assembled
43S pre-initiation complex binds the mRNA at the cap structure
via interaction of a central domain of eIF4G with eIF3. The bound
pre-initiation complex scans along the RNA until an AUG start
codon is recognized in a favorable context [1], at which point GTP
is hydrolyzed to GDP in the presence of eIF5. Large ribosomal
subunit joining then occurs to generate an elongation-competent
80S ribosome and protein synthesis begins; initiation factors are
recycled for subsequent rounds of initiation. The cellular protein
poly(A)-binding protein (PABP), which binds the 39 poly(A) tracts
of cellular mRNAs and interacts with eIF4G, allows for
circularization of the mRNA and provides a context for multiple
rounds of translation initiation. Changes to the cellular environ-
ment, which can occur during viral infection or under various
conditions of stress, can result in a down-regulation of cap-
dependent translation often by interfering with initiation factors
that play important roles in cap-dependent translation initiation.
Unlike cap-dependent translation, the mechanism of cap-
independent ribosome recruitment to the RNA has not been fully
defined (see Figure 1B). The 40S ribosomal subunit recognizes an
RNA sequence, structure, or ribonucleoprotein complex within
the 59 noncoding region (59 NCR) of the RNA, and translation
initiation can occur several hundred nucleotides downstream from
the 59 end of the RNA. A 59 cap is not required for assembly of
initiation factors for this alternative form of initiation, so cap-
recognition of the 40S ribosomal subunit via the intact eIF4F cap
binding complex does not occur. In addition, the RNA is generally
highly structured in nature, and ribosomes may not be capable of
scanning through the noncoding region to reach the authentic
initiation site. Therefore, initiation involves the internal binding of
ribosomes to the RNA. Thus, cap-independent translation
involves features that are distinct from the canonical cap-binding,
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differences between cap-dependent and cap-independent transla-
tion initiation.
Internal entry of ribosomes for translation initiation was first
observed for picornavirus RNAs, and has since been identified in
other viruses as well as a subset of cellular mRNAs (for review, see
[2,3,4]). The poliovirus and encephalomyocarditis virus (EMCV)
viral genomic RNAs were the first RNAs found to contain sequences
in their 59 NCRs, termed internal ribosome entry sites (IRESes),
which mediate the internal binding of ribosomes for translation
initiation [5,6,7]. During almost all picornavirus infections, cap-
dependent translation isshut-down via cleavage oftranslation factors
by viral proteinases. The viruses utilize IRES-mediated translation
initiation to direct the synthesis of viral proteins.
Picornaviruses are cytoplasmic RNA viruses containing a
,7.0 kb–8.5 kb positive-sense single-stranded genome. This
genomic RNA encodes a single open-reading frame, which is
translated to generate a polyprotein that is proteolytically
processed. Viral proteinases 2A and 3C cleave several cellular
proteins, including eIF4G, to down-regulate host cell translation
during poliovirus, human rhinovirus, or coxsackievirus infection.
Other work has shown that poliovirus and coxsackievirus
proteinases cleave PABP and that this cleavage correlates with
host cell translation shut-off [8,9,10,11,12,13]. The virus can then
utilize available translation machinery and host cell proteins to
direct IRES-mediated translation of viral proteins and no longer
has to compete with cellular mRNA translation for these factors.
Owing to their limited coding capacity, picornaviruses have
evolved to utilize certain host cell proteins along with encoded viral
proteins and RNA secondary structures to direct viral translation
and RNAreplication. Certain IRES trans-activating factors(ITAFs)
are known to bind to the 59 NCRs of picornavirus RNAs, and a
subset of these has been shown to have an effect on viral translation
(for review, see [2,4]). Poly(rC) binding protein 2, or PCBP2, is one
ITAF that has been extensively studied for its role in picornavirus
translation. PCBP2 is a 38 kDa cellular RNA binding protein that
has been associated with RNA stability and translational regulation
of cellular mRNAs [14]. This protein is also known to bind the 59
NCRofseveralpicornavirus RNAs [15]. Forpoliovirus, the binding
of PCBP2 to stem-loop IV in the IRES is required for translation,
and depletion of PCBP2 from cell-free extracts results in a dramatic
decrease in viral translation [16,17]. Poliovirus also requires the
interaction of PCBP2 with cellular splicing factor SRp20, and these
two proteins have been shown to function synergistically in
poliovirus translation [18]. The specific role this interaction plays
in viral translation is not yet completely understood.
SR proteins are a family of splicing factors that function in
constitutive splicing as well as in alternative splice site selection in the
nucleus of eukaryotic cells [19]. Members of the SR family of
proteins contain one or more RNA-recognition motifs (RRMs) at
their N-termini and a serine/arginine-rich (RS) domain at their C-
termini. The RRM domains are involved in RNA binding, and the
RS domain has been implicated in protein shuttling and protein-
protein interactions [20,21]. SRp20 is a 20 kDa RNA binding
protein that shuttles between the nucleus and cytoplasm of cells, and
contains one RRM and one RS domain. SR proteins have been
extensively studied, and much of the early work focused on mRNA
splicing and stability. Beyond their resident functions in the nucleus,
several SR proteins (including SRp20) have also been implicated in
mRNA nuclear export in eukaryotic cells, and provide a possible
connection between splicing, export, and translation ([22]; for
review, see [23,24]). More recently it was proposed that the SR
protein ASF/SF2 functions in cap-dependent translation, and that
SR protein 9G8 functions in the translation of unspliced mRNAs
containing a constitutive transport element [24,25,26]. In addition,
SRp40 and SRp55 were found to promote HIV-1 Gag translation
from unspliced, intron-containing viral RNAs; thus, it was proposed
that SR proteins couple HIV-1 genomic RNA biogenesis to
translation functions [27]. Taken together, these recent studies
suggest a role for SR proteins in linking nuclear splicing and export
with translation in eukaryotic cells, and provide evidence for the role
of SR proteins in both cap-dependent translation and translation of
certain viral RNAs.
In this study we sought to further define the mechanism of
ribosome recruitment to poliovirus RNA, focusing specifically on
the role of the interaction between PCBP2 and SRp20. We
observed a dramatic re-localization of SRp20 from the nucleus to
the cytoplasm of poliovirus-infected cells, where we also observed
partial co-localization with PCBP2 during infection. Using sucrose
gradient sedimentation of extracts from poliovirus-infected cells,
we demonstrated that both PCBP2 and SRp20 partially co-
sediment in translation initiation complex-containing fractions.
We also determined that SRp20 is associated with PCBP2 bound
to poliovirus stem-loop IV. Finally, we designed a deleted version
of SRp20 lacking one of its functional domains (denoted
SRp20DRRM), and determined that its localization in mock-
and poliovirus-infected cells (and co-localization with PCBP2)
resembled that of the wild type SRp20 protein. Significantly,
expression of SRp20 lacking the RRM domain resulted in an
approximate two-log decrease in virus yield for poliovirus when
compared to expression of wild type SRp20. Taken together, these
results support the model that SRp20 interacts with PCBP2 on
poliovirus RNA, and this interaction functions either directly or
indirectly to recruit the translation machinery to the viral RNA for
IRES-mediated translation initiation.
Materials and Methods
Cell culture and DNA constructs
HeLa cells [28,29] were grown in suspension culture or as
monolayers in Dulbecco’s Modified Eagle’s Media (DMEM)
Author Summary
Picornaviruses are positive-sense RNA viruses that cause
diseases ranging from the common cold to poliomyelitis.
Poliovirus is one of the most extensively studied members
of the Picornaviridae family. However, a complete under-
standing of the mechanism by which the viral RNA
genome directs the synthesis of its protein products is
lacking. Poliovirus usurps the host cell translation machin-
ery to initiate viral polyprotein synthesis via a mechanism
distinct from the cellular cap-binding, ribosome scanning
model of translation. This allows the virus to down-
regulate host cell translation while providing an advantage
for its own gene expression. Owing to its small genome
size, poliovirus utilizes host cell proteins to facilitate the
recruitment of the translation machinery, a process that is
still not completely defined. Previous work highlighted the
importance of two particular host cell RNA binding
proteins in poliovirus translation. Here we employ imaging
techniques, fractionation assays, and RNA binding exper-
iments to further examine the specific role these proteins
play in poliovirus translation. We also generated a
truncated version of one of the proteins and observed a
dramatic effect on virus growth, highlighting its signifi-
cance during poliovirus infection and supporting our
model for bridging the cellular translation apparatus to
viral RNA.
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(American Type Culture Collection number: HTB-11) cells were
grown in DMEM supplemented with 20% fetal calf serum (FCS).
For imaging experiments, pEGFP and pEGFP-SRp20 plasmids
(containing CMV promoters for expression) were kindly provided
by Dr. Roz Sandri-Goldin. To generate the SRp20 deletion
mutant SRp20DRRM, an EcoRI site was engineered at the
beginning of the coding sequence for the RS domain (preceding
the TAP-binding region, [30]). Following digestion to remove the
RRM fragment that was produced, the linear vector was gel-
purified, phenol-chloroform extracted and ethanol precipitated,
and then re-ligated with T4 DNA ligase (New England BioLabs) to
re-circularize the plasmid. Removal of the RRM was verified via
sequencing. For DNA co-transfection experiments, poliovirus
pPVA55 cDNA [31] was utilized. For RNA affinity assays, stem-
loop IV RNA was generated from poliovirus subclone cDNA
p220–460 [32].
Laser Scanning Confocal Microscopy (LSCM) experiments
SK-N-SH cells or HeLa cells seeded on coverslips in a six-well
plate format, and allowed to grow to approximately 70%
confluency. Cells were transfected with pEGFP, pEGFP-SRp20,
or pEGFP-SRp20DRRM using Fugene transfection reagent
(Roche). Twenty-four hours post-transfection, cells were infected
with poliovirus [multiplicity of infection (MOI)=25], and at
specific times post-infection cells were washed with phosphate-
buffered saline (PBS) and fixed with 3.7% paraformaldehyde at
room temperature for 20 min. Cells were washed with PBS twice,
and cell membranes were permeabilized with 0.5% NP-40 in PBS
for 5 min. Cells were washed with 1% NCS in PBS and incubated
with normal donkey serum (Jackson ImmunoResearch) for one
hour to block nonspecific interactions. Cells were then incubated
with a monoclonal antibody against PCBP2 [33] for one hour.
Cells were washed and incubated with a goat-anti mouse
secondary antibody conjugated with biotin (Pierce) for 30 min,
and then incubated with streptavidin conjugated with Texas Red
(GE Healthcare) for 30 min. Cells were washed with 1% NCS-
PBS and incubated with DAPI to stain nuclei. Cells were washed
with PBS, and coverslips were mounted on microscope slides with
mounting media (Biomeda) and allowed to dry overnight at room
temperature. Coverslips were sealed with nail polish, and cells
were imaged using a Zeiss LSM 510 multi-photon laser scanning
Figure 1. Recruitment of the 43S pre-initiation complex for cap-dependent and cap-independent translation initiation. For cap-
dependent translation initiation (Figure 1A), the eIF4F cap-binding complex recognizes and binds to the 59 cap structure of the mRNA. Following cap
binding and ribosome scanning mediated by the 43S pre-initiation complex, initiation occurs at an AUG in a favorable context. After GTP hydrolysis
and 60S subunit joining, the ribosome is elongation-competent and protein synthesis begins. In the cap-independent mechanism of translation
initiation (Figure 1B), the 43S pre-initiation complex associates with RNA sequences in the IRES either directly or in conjunction with canonical or non-
canonical initiation factors, which facilitates initiation at the appropriate AUG start codon. Non-canonical factors are indicated as IRES trans-acting
factors, or ITAFs. This figure highlights the major differences in the mechanisms of cap-dependent and cap-independent translation, and is not a
comprehensive model for eukaryotic translation initiation. Additional canonical factors (such as eIF4G and eIF4B) as well as non-canonical factors
have been shown to bind to the poliovirus IRES and/or stimulate poliovirus translation. (Figure taken from [2], with permission).
doi:10.1371/journal.ppat.1002127.g001
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software.
Generation of cytoplasmic extracts from mock- and
poliovirus-infected cells
HeLa cells were grown in suspension culture to approximately
6610
5 cells/ml. Cells were pelleted and resuspended in DMEM to
a concentration of approximately 5610
6 cells/ml. Cells were
mock-infected or infected with poliovirus (MOI=25) in spinner
flasks. At each hour post-infection an aliquot of cells was
withdrawn from each flask, incubated with cycloheximide for
5 min, and then pelleted. Cell pellets were washed twice with ice-
cold PBS and resuspended in 0.3% NP-40 lysis buffer (20 mM
Tris pH 7.5, 5 mM MgCl2, 100 mM KCl, 0.3% NP-40, 0.1 mg/
ml cycloheximide). Cells were lysed for 20 min on ice, and lysates
were cleared by centrifugation at 5,0006 g for 10 min at 4uC.
Lysates were aliquoted and stored at 270uC until use.
Sucrose gradient fractionation of cytoplasmic extracts
A two-chamber mixer was used to generate 7%–47% (w/w)
sucrose gradients (comprised of 20 mM Tris pH 7.5, 5 mM
MgCl2, and 100 mM KCl). An aliquot of extract from either
mock- or poliovirus-infected cells was thawed and carefully
overlaid onto the top of the gradient. Gradients were centrifuged
for two hours at 35,000 RPM at 4uC in a Beckman SW41
swinging bucket rotor. Following centrifugation, gradients were
fractionated using an Isco fractionator by piercing at the bottom of
the tube and chasing the gradient with a 60% sucrose solution.
Fractions were collected with concomitant measurement of the
OD 254 nm and were stored at 270uC until further processing.
For Western blot analysis, antibodies were used to detect the
sedimentation of ribosomal subunits and assembled ribosomes
(anti-S6, Cell Signaling; anti-P0, ImmunoVision). Antibodies
against eIF2a (Cell Signaling) and PABP (a gift from Dr. Richard
Lloyd) were used to detect the sedimentation of these proteins.
PCBP2 antibody was previously described [33]; an antibody
against SRp20 was obtained from Invitrogen.
RNA affinity assays
Plasmid subclone DNA p220–460 [32] was linearized with
HindIII (New England BioLabs), phenol-chloroform extracted,
and ethanol precipitated. Transcript RNA was produced from
linear DNA with the T7 MegashortScript Kit (Ambion) using a 4:1
ratio of Biotin-CTP (Invitrogen) to CTP. Biotinylated transcript
RNA was purified using an RNeasy column (Qiagen). Interaction
of the biotinylated RNA with streptavidin protein was verified
using agarose gel shift analysis (data not shown). For RNA affinity
experiments, 500 pmol of biotinylated stem-loop IV RNA was
used per reaction and tRNA (25 mg/ml) was included as a control
for nonspecific interactions. Biotinylated stem-loop IV RNA was
incubated with streptavidin agarose (Sigma) for one hour on ice
with occasional vortexing to allow for association of the RNA with
the matrix. The agarose was washed twice in 400 mlo f5 0m M
KCl buffer (50 mM KCl, 5% glycerol, 1 mM DTT, 0.5 mM
EDTA pH 8, 2.5 mM MgCl2,2 5 mg/ml tRNA) and then
resuspended in 400 ml of 50 mM KCl buffer. Extracts described
previously for sucrose gradient fractionation (from poliovirus-
infected cells at three or four hours post-infection) were utilized as
a source of PCBP2 and SRp20. 400 mg of extract was initially pre-
cleared by incubating the extract with streptavidin agarose on ice
for one hour. The agarose was pelleted and removed, and pre-
cleared extract was incubated with biotinylated stem-loop IV-
streptavidin agarose for two hours on ice, vortexing occasionally.
Bound complexes were washed three times with 100 mM KCl
buffer (same as 50 mM KCl buffer except for the higher
concentration of KCl) and resuspended in 50 ml2 6 Laemmli
sample buffer. Samples were boiled and subjected to SDS-PAGE
and Western blot analysis. When poly(rC) was included as a
competitor for PCBP2 binding, 1 nmol synthetic poly(rC) RNA
(Thermo Scientific) was pre-incubated with the pre-cleared extract
for 1 hour on ice prior to incubation with the biotinylated
poliovirus stem-loop IV-streptavidin agarose.
Poliovirus growth assays
HeLa cells were plated in 60 mm dishes and grown to
approximately 70% confluency. Cells were co-transfected with
poliovirus cDNA plasmid pPVA55 and either pEGFP, pEGFP-
SRp20, or pEGFP-SRp20DRRM using Fugene transfection
reagent (Roche). Ninety-six hours post-transfection, cells and
media were harvested via scraping. Virus was released by five
cycles of freeze-thaw, and virus samples were serially-diluted.
Dilutions were used to infect HeLa cells (80–90% confluent) in
60 mm dishes; following a 30 min adsorption period at room
temperature, a 0.45% agarose-DMEM overlay was added to the
cells, and plaques were allowed to develop. After 24 hours,
another layer of 0.45% agarose-DMEM was added to the cells.
After 48 hours, cells were treated with 10% TCA, and plaques
were stained with crystal violet and counted. All experiments were
carried out in triplicate.
Results
SRp20 displays a dramatic re-localization from the
nucleus to the cytoplasm of the cell during poliovirus
infection
We first determined the subcellular localization of SRp20
during poliovirus infection. To visualize SRp20 in the cell, we
transfected a plasmid encoding a GFP-tagged version of the
protein into SK-N-SH cells, a neuroblastoma cell line permissive
for poliovirus infection. We subsequently utilized confocal
microscopy to capture fixed images of SRp20 localization in
mock- and poliovirus-infected cells over a time course. The results
of these experiments are shown in Figure 2. SRp20 is a nuclear
splicing factor, therefore we expected this protein to be localized
predominantly in the nucleus in cells under normal conditions,
with a portion of the protein shuttling between the nucleus and the
cytoplasm. Since SRp20 is important for poliovirus infection,
which occurs in the cytoplasm of the cell, we predicted that we
would observe a greater amount of SRp20 in the cytoplasm of
poliovirus-infected cells compared to mock-infected cells. We
determined that SRp20 is indeed predominantly localized in the
nucleus in mock-infected cells (see Figure 2A), and this localization
in mock-infected cells did not change over the time course that was
carried out (data not shown). While a portion of the SRp20
shuttles between the nucleus and the cytoplasm, the prominent
signal in the nucleus precludes visualizing the small portion of
SRp20 in the cytoplasm at any given time (which is consistent with
published data for this protein, [34]). At 1 hour post-infection
SRp20 remained predominantly nuclear in localization
(Figure 2B). However, at 2 hours post-infection SRp20 could be
visualized re-localizing to some extent to the cytoplasm of the
infected cell (Figure 2C). At 3 hours post-infection, a more
dramatic re-localization of SRp20 into the cytoplasm of the
infected cell was observed (Figure 2D). Later in infection (4 and
5 hours post-infection, Figure 2E and 2F), much of the SRp20 was
localized in the cytoplasm of the cell with little of the protein
remaining in the nucleus. The presence of cytoplasmic SRp20 was
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blot analysis (Figure 3). Equal total protein amounts of extracts
from both mock- and poliovirus-infected cells (1 through 4 hours)
were subjected to SDS-PAGE and examined via Western blot,
probing with an SRp20 monoclonal antibody. SRp20 was found
in both types of cytoplasmic extracts at all times examined. The
increased accumulation of SRp20 in the cytoplasm of infected cells
could also be observed in the Western blot, beginning about
2 hours post-infection (compare lanes 3 and 4) and it continued to
increase over the course of infection (compare lanes 5 and 6, and
lanes 7 and 8). Thus, SRp20 re-localizes to a large extent from the
nucleus to the cytoplasm of cells during poliovirus infection, and
can be visualized re-localizing to the cytoplasm beginning about
2 hours post-infection.
Other work has examined the nucleo-cytoplasmic trafficking of
proteins during poliovirus infection in HeLa cells (for example,
[35]); in addition, a portion of our studies presented here include
biochemical work utilizing these cells. Therefore, we also
investigated SRp20 localization during poliovirus infection in
HeLa cells (Figure 4). Similar to what is seen in SK-N-SH cells,
SRp20 is predominantly nuclear in mock-infected cells (Figure 4A),
and remains mostly nuclear at 1 hour post-infection (Figure 4B).
At 2 hours post-infection, SRp20 begins to re-localize to the
cytoplasm of the infected cell (Figure 4C), which becomes very
apparent at 3 hours post-infection (Figure 4D). Figure 4E and 4F
show the dramatic re-localization of SRp20 at later times post-
infection with poliovirus. Additional experiments were also carried
out using a monoclonal antibody to label endogenous SRp20, and
we determined that the endogenous protein re-localizes from the
nucleus to the cytoplasm during poliovirus infection (data not
shown). Transfection of the GFP-tagged version of the protein
provided the advantage of a consistent signal from the GFP
fluorescence, in contrast to labeling SRp20 with the monoclonal
antibody, which resulted in a higher variability of the signal
produced. GFP-SRp20 has been previously characterized to
localize and function similarly to endogenous SRp20 [36]. We
also determined that the GFP tag alone does not contribute to the
localization of the protein (data not shown).
SRp20 partially co-localizes with PCBP2 in the cytoplasm
of poliovirus-infected cells
It has been previously shown that SRp20 interacts with PCBP2,
and this interaction is required for poliovirus IRES-mediated
translation [18]. These studies utilized in vitro assays such as co-
immunoprecipitations using extracts from poliovirus-infected
HeLa cells, and GST pull down assays using recombinant PCBP2
and SRp20. To further study this interaction in intact cells during
poliovirus infection, we transfected neuroblastoma cells (SK-N-
SH) with the GFP-SRp20 plasmid and subsequently infected with
poliovirus. Cells were fixed at 3 hours post-infection and then
labeled with a PCBP2 antibody. To determine the subcellular
location of these two proteins and their predicted close association
with each other, we again used confocal microscopy to visualize
potential co-localization of SRp20 and PCBP2. The results of
these experiments are shown in Figure 5. We took advantage of
the SK-N-SH cell line for these co-localization experiments
because we expected that co-localization of PCBP2 and SRp20
would occur in the cytoplasm of the cell, and SK-N-SH cells have
a more distinct cytoplasmic space compared to other cell types,
such as HeLa cells. We examined cells at 3 hours post-infection
because sufficient amounts of SRp20 would be expected to be re-
localized into the cytoplasm of the cell, where potential co-
localization with PCBP2 could be visualized. In the mock-infected
cells, SRp20 is predominantly nuclear in localization (as observed
previously in Figure 2) while PCBP2 was found to be localized in
both the nucleus and the cytoplasm (consistent with published
results for this protein [37,38], see Figure 5A). At 3 hours post-
infection SRp20 re-localized to the cytoplasm of the infected cell
and partially co-localized with PCBP2 (shown in Figure 5B).
Neither PCBP2 nor SRp20 occupied all of the cytoplasmic space
in the infected cells, as regions could be observed to contain one
protein or the other, but not both. The co-localization observed
was in the cytoplasm of the infected cell and was distinct from the
nucleus; this was confirmed via z-stack analysis (data not shown).
The z-stacks of some images were further processed using the
Volocity Image Analysis Software (PerkinElmer) to generate
rotational movies of the cells in three-dimensions (see Video S1).
Thus, SRp20 and PCBP2 can be visualized in very close proximity
to each other in the cytoplasm of intact cells during poliovirus
infection.
SRp20 and PCBP2 partially sediment in translation
initiation complex-containing fractions generated using
extracts from mock- or poliovirus-infected cells
SRp20 and PCBP2 are both important for poliovirus IRES-
mediated translation, as depletion of one or both proteins reduces
levels of viral translation. To investigate whether SRp20 and
PCBP2 are associated with translation initiation complexes and/or
actively translating polysomes, we carried out sucrose gradient
fractionation of extracts from mock- or poliovirus-infected HeLa
cells. Fractionation of extracts generated polysome profiles, which
were used to determine the sedimentation of ribosomal subunits
(40S and 60S peaks), assembled monosomes (80S peak), and
actively translating polysomes (multiple peaks observed in the
heavier portions of the gradient), as well as associated RNAs and
proteins. We initially used Western blot analysis of the sedimen-
tation of small ribosomal subunit protein S6 and large ribosomal
subunit protein P0 to determine the identity of the peaks in the
polysome profiles generated during fractionation (shown in
Figures 6–8). Subsequent Western blot analysis was used to
identify fractions containing canonical translation factors (shown
using an antibody directed against eIF2a), PCBP2, and SRp20.
In Figure 6, extracts from mock-infected cells consistently
generated high levels of polysomes due to high levels of cap-
dependent translation occurring in the cells. In extracts from
mock-infected cells, PCBP2 was found mostly at the top of the
gradient, as well as partially sedimenting in fractions containing
40S ribosomal subunits. SRp20 was found to sediment in 40S
subunit-containing fractions, as well as 80S monosome-containing
fractions. Neither PCBP2 nor SRp20 were found to co-sediment
with polysomes, indicating these proteins do not remain associated
with actively translating ribosomes. The sedimentation of PCBP2
somewhat resembles the sedimentation of eIF2a, a canonical
translation initiation factor. Poly(A)-binding protein (PABP) was
found to co-sediment with 80S monosomes and polysomes,
Figure 2. SRp20 re-localization from the nucleus to the cytoplasm of SK-N-SH cells during poliovirus infection. Cells were transfected
with GFP-SRp20 and either mock-infected (A) or infected with poliovirus at an MOI of 25. Cells were fixed at specific times post-infection (1–5 hours,
B–F) and imaged. SRp20 localization was determined using confocal microscopy; nuclei were identified by DAPI staining.
doi:10.1371/journal.ppat.1002127.g002
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translation.
Figure 7 shows the polysome profile and Western blot analysis
of fractions collected using extracts from poliovirus-infected cells at
2 hours post-infection. In this profile the polysome portion was
reduced when compared to the profile for mock-infected cells.
This would be expected, since at 2 hours post-infection much of
the cap-dependent translation has been shut down. The polysomes
observed here likely represent the remaining cap-dependent
translation that was occurring, as well as poliovirus cap-
independent translation. The Western blot analysis of these
fractions was similar to that of the fractions collected from extracts
from mock-infected cells; PCBP2 was found to sediment mainly at
the top of the gradient as well as partially sedimenting in 40S
fractions, while SRp20 was found in 40S and 80S fractions.
Therefore, PCBP2 and SRp20 sediment in similar fractions when
using extracts from mock- and poliovirus-infected cells.
The polysome profile and Western blot analysis of fractions
collected using extracts from cells at 5 hours post-infection are
shown in Figure 8. Interestingly, PABP is found to redistribute to
the lighter portion of the gradient, and no longer co-sediments
with polysomes at 5 hours post-infection. This observation is
consistent with some published studies [13,39] but not others [40].
There is also a lack of detectable polysomes at this time point late
in infection, which is consistent with previously published work
[41,42,43]. PCBP2 co-sediments partially with 40S ribosomal
subunits, while SRp20 co-sediments with 40S subunits and 80S
monosomes. Importantly, much more SRp20 appears in the
fractions from cytoplasmic extract generated at 5 hours post-
infection, which is consistent with our microscopy data indicating
that much of the nuclear SRp20 re-localizes to the cytoplasm
during poliovirus infection. Taken together, SRp20 and PCBP2
were found, at least in part, in fractions containing viral translation
initiation complexes in both mock- and poliovirus-infected cells.
SRp20 interacts with PCBP2 bound to poliovirus
stem-loop IV
We next investigated whether SRp20 interacts with PCBP2 on
poliovirus RNA. The interaction of PCBP2 with poliovirus RNA
has been extensively studied in previous work [17,44,45]. Since
SRp20 interacts with PCBP2 in extracts from poliovirus-infected
HeLa cells, we wanted to determine whether this interaction
occurs while PCBP2 is bound to the viral RNA. To address this
question, we carried out RNA affinity assays using poliovirus
stem-loop IV RNA and extracts from poliovirus-infected cells.
Stem-loop IV RNA was transcribed and biotinylated using
Biotin-CTP, the purified biotinylated RNA was incubated with
extracts from poliovirus-infected cells, and bound complexes were
isolated using streptavidin-agarose. Bound complexes were
resolved and analyzed via Western blot. Figure 9 shows the
representative results from four different RNA affinity assays. As
expected, PCBP2 was associated with the biotinylated stem-loop
Figure 3. SRp20 is present in cytoplasmic extracts from both mock- or poliovirus-infected cells. Cytoplasmic extracts from mock- or
poliovirus-infected cells (hours 1 through 4 as indicated) generated for sucrose gradient fractionation were also examined for the presence of SRp20.
Extracts (100 mg of total protein) were subjected to SDS-PAGE and Western blot analysis, probing with an SRp20 monoclonal antibody. Lanes marked
‘M’ are extracts from mock-infected cells; lanes marked ‘PV’ are extracts from poliovirus-infected cells.
doi:10.1371/journal.ppat.1002127.g003
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PLoS Pathogens | www.plospathogens.org 7 July 2011 | Volume 7 | Issue 7 | e1002127Figure 4. SRp20 re-localization from the nucleus to the cytoplasm of HeLa cells during poliovirus infection. Cells were transfected with
GFP-SRp20 and either mock-infected (A) or infected with poliovirus at an MOI of 25. Cells were fixed at specific times post-infection (1–5 hours, B–F)
and imaged. SRp20 localization was determined using confocal microscopy; nuclei were identified by DAPI staining.
doi:10.1371/journal.ppat.1002127.g004
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tRNA alone (Figure 9A, lane 2). Using this assay we were also
able to determine that SRp20 is associated with PCBP2 bound to
poliovirus stem-loop IV (Figure 9B, lane 3). Only background
amounts of SRp20 were detected with tRNA alone (Figure 9B,
lane 2). The RNA affinity experiments were repeated as
described above, but with an additional control. When extracts
were pre-incubated with synthetic poly(rC) RNA, previously
shown to compete for PCBP2 binding [15], PCBP2 no longer
interacted with the biotinylated poliovirus stem-loop IV RNA
(Figure 9C, lane 4). In addition, SRp20 was no longer associated
with S-L IV (Figure 9D, lane 4), suggesting that SRp20 is not
associated with the viral RNA when PCBP2 is not bound. Thus,
the interaction of SRp20 with PCBP2 appears to occur on viral
RNA. Importantly, we have also utilized electrophoretic mobility
shift assays to determine that SRp20 does not directly bind to
poliovirus S-L IV (unpublished results).
The subcellular localization of an RRM-deleted form of
SRp20 is similar to the full-length SRp20 protein
Previous studies have outlined the requirement of the serine/
arginine-rich (RS) domain of SRp20 for interaction with
PCBP2 [18]. To better define the functional role of SRp20 in
poliovirus IRES-mediated translation we generated a deleted
form, SRp20DRRM, which contains a deletion of the entire
RNA-recognition motif (RRM) but still possesses the RS
domain. We hypothesized that an SRp20 protein lacking one
of its functional domains would act as a dominant-negative
protein when overexpressed in cells during poliovirus infection,
effectively sequestering PCBP2 from functional viral translation
complexes.
To first determine the localization of this protein in the cell,
the mutation was generated in the GFP-SRp20 clone;
therefore, confocal microscopy could be employed to visualize
its localization in mock- and poliovirus-infected cells. Since the
RS domain acts as a nuclear localization signal for SR proteins
[20,46,47], we predicted that the localization of the deleted
form of the protein would be similar to wild type SRp20. This
prediction was supported by studies on the Drosophila
homologue of SRp20 (Rbp1); when the RRM domain was
deleted from Rbp1 the protein localized like wild type Rbp1 in
insect cells [48]. The results of our experiments in SK-N-SH
cells are shown in Figure 10. Cells were mock-infected or
infected with poliovirus, and at the indicated times cells
were fixed and imaged to determine the localization of
SRp20DRRM. Expression alone of the deleted form of
SRp20 did not affect cell viability (data not shown). In mock-
infected cells, SRp20DRRM was located predominantly in the
nucleus, similar to the wild type SRp20 (see Figure 10A). The
localization of SRp20DRRM in mock-infected cells did not
c h a n g eo v e rt h et i m ec o u r s et h a tw a sc a r r i e do u t( d a t an o t
shown). During the course of poliovirus infection, the deleted
form of SRp20 re-localized to the cytoplasm of the infected cell,
which could be visualized beginning about 2 hours post-
infection (Figure 10C). The localization of SRp20DRRM
resembled the localization of wild type SRp20, as both proteins
re-localized to the cytoplasm after poliovirus infection.
SRp20DRRM accumulation in the cytoplasm of the cell
increased over the course of infection (Figure 10D–F).
Interestingly, SRp20DRRM appeared to re-localize to a
somewhat greater extent at earlier times post-infection when
compared to the wild type protein (compare Figures 2C and
10C). This observation was made in the majority of cells when
comparing the localization of the full length and deleted forms
of SRp20 during poliovirus infection.
SRp20DRRM partially co-localizes with PCBP2 in the
cytoplasm of poliovirus-infected SK-N-SH cells
Because the deleted form of SRp20 contains the RS domain, we
proposed that this protein would still interact with PCBP2, and
therefore would be found in close proximity to PCBP2 in the
cytoplasm of poliovirus-infected cells. To test this we carried out
immunofluorescence experiments using a PCBP2 monoclonal
antibody to investigate whether SRp20DRRM co-localized with
Figure 5. SRp20 partial co-localization with PCBP2 in the cytoplasm of poliovirus-infected SK-N-SH cells. Cells were transfected with
GFP-SRp20 and mock-infected (A) or infected with poliovirus for 3 hours (B) at an MOI of 25. At 3 hours post-infection, cells were fixed and incubated
with a PCBP2 monoclonal antibody, a secondary antibody conjugated to biotin, and streptavidin conjugated to Texas Red. Cells were examined for
co-localization of PCBP2 and SRp20 (shown in the merged image in yellow and highlighted by the white arrow) in the cytoplasm of the cells using
confocal microscopy; nuclei were identified by DAPI staining.
doi:10.1371/journal.ppat.1002127.g005
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we again observed that SRp20DRRM was predominantly nuclear
in the mock-infected cells, while PCBP2 was localized in both the
nucleus and the cytoplasm (Figure 11A). We were able to
determine that SRp20DRRM partially co-localizes with PCBP2
at 3 hours post-infection in the cytoplasm of the infected cell (see
Figure 11B). This co-localization occurred in an area of the
cytoplasm distinct from the nucleus, and was confirmed via z-stack
analysis (data not shown). These experiments showed that
SRp20DRRM was able to co-localize with PCBP2, which we
predicted would occur since the deletion construct still contains the
domain required for interaction with PCBP2. Interestingly, the
co-localization appeared to occur in areas that likely do not
contain active viral translation complexes (such as the cellular
periphery), in contrast to what is seen for the full length SRp20.
This observation would support our hypothesis that the deleted
Figure 6. SRp20 and PCBP2 co-sedimentation with 40S ribosomal subunits in mock-infected cells. Extracts were generated from mock-
infected HeLa cells, sedimented through 7%–47% sucrose gradients and fractionated. The collected fractions were subjected to Western blot analysis
to determine the co-sedimentation of PCBP2 and SRp20 with ribosomal subunits, monosomes, or polysomes. Representative polysome profiles and
Western blot analyses are shown.
doi:10.1371/journal.ppat.1002127.g006
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sequester PCBP2 from active viral translation complexes, resulting
in the formation of non-functional complexes found in areas of the
cell where viral translation is likely not occurring.
Expression of SRp20DRRM results in a decrease in
poliovirus yield
If the deleted form of SRp20 functions as a dominant-negative
protein, we would expect that its expression would result in a
decrease in poliovirus yield. We predicted that SRp20DRRM,
owing to its remaining RS domain, would interact with PCBP2
and effectively sequester PCBP2 from functional poliovirus
translation complexes. If PCBP2 is sequestered away from
functional viral translation complexes, this would hinder the
progression of the infection and result in lower titers of virus
produced. To test this we carried out DNA co-transfections,
utilizing the GFP-tagged SRp20 or GFP-SRp20DRRM (or vector
alone) and a recombinant plasmid harboring an infectious cDNA
copy of the poliovirus (type 1) genome. This experimental design
provided us the advantage of ensuring that every transfected cell
would likely express both plasmids; therefore, virus would be
produced under the influence of the expression of wild type SRp20
Figure 7. SRp20 and PCBP2 co-sedimentation with 40S ribosomal subunits in poliovirus-infected cells (2 hr post-infection). Extracts
were generated from poliovirus-infected HeLa cells after 2 hours of infection and processed as described in the legend for Figure 6. Representative
polysome profiles and Western blot analyses are shown.
doi:10.1371/journal.ppat.1002127.g007
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vector alone). This also provided an advantage in timing of
expression, since the DNA plasmids should be expressed along a
similar timeline. Importantly, however, the CMV promoter-driven
expression of the full length and deleted forms of SRp20 would
result in high levels of these proteins being generated well before
any virus production from the poliovirus cDNA (see Figure 12A).
Cells were co-transfected with the poliovirus cDNA plasmid and
either a plasmid expressing wild type SRp20 fused to GFP or
SRp20DRRM fused to GFP (or GFP-expressing vector alone) and
Figure 8. SRp20 and PCBP2 co-sedimentation with 40S ribosomal subunits in poliovirus-infected cells (5 hr post-infection). Extracts
were generated from poliovirus-infected HeLa cells after 5 hours of infection and processed as described in the legend for Figure 6. Representative
polysome profiles and Western blot analyses are shown. The sedimentation of virus (labeled ‘virus peak’ in the profile) was determined by Western
blot analysis of fractions using an anti-VP2 polyclonal antibody that detects the poliovirus VP2 capsid protein (Holzberg, Nguyen, and Semler,
unpublished).
doi:10.1371/journal.ppat.1002127.g008
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extracts were also generated and probed with anti-SRp20
monoclonal antibody to ensure high levels of expression of both
full length SRp20 and the deleted form (see Figure 12A). Following
virus harvest and dilution, plaque assays were carried out to
determine the effect of SRp20 or SRp20DRRM expression on
Figure 9. Interaction of PCBP2 and SRp20 on poliovirus stem-loop IV RNA. Poliovirus stem-loop IV RNA was transcribed and biotinylated
with Biotin-CTP. The purified RNA (lane 3 in A and B) or tRNA alone (lane 2 in A and B) was incubated with streptavidin agarose, and the RNA-affinity
matrix was subsequently incubated with extracts from poliovirus-infected cells (4 hours post-infection). Bound complexes were examined by Western
blot analysis for the presence of PCBP2 and SRp20. Lane 1 in A and B, input extract (20% of experimental). The experiments were repeated exactly as
described above, but included an additional experimental control. Extracts were incubated with tRNA alone (lane 2 in C and D), with biotinylated S-L
IV RNA (lane 3 in C and D), or biotinylated S-L IV RNA and synthetic poly(rC) RNA (lane 4 in C and D) as a competitor for PCBP2 binding. Lane 1 in C
and D, input extract (20% of experimental).
doi:10.1371/journal.ppat.1002127.g009
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PLoS Pathogens | www.plospathogens.org 13 July 2011 | Volume 7 | Issue 7 | e1002127Figure 10. SRp20DRRM re-localization from the nucleus to the cytoplasm of SK-N-SH cells during poliovirus infection. Cells were
transfected with GFP-SRp20DRRM and either mock-infected (A) or infected with poliovirus at an MOI of 25. Cells were fixed at specific times post-
infection (1–5 hours, B–F) and imaged. SRp20DRRM localization was determined using confocal microscopy; nuclei were identified by DAPI staining.
doi:10.1371/journal.ppat.1002127.g010
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shown in Figure 12B and 12C. Expression of vector alone or of
wild type SRp20 resulted in similar titers of poliovirus, while the
expression of SRp20DRRM lowered the titers of virus produced
by ,100 fold. Thus, we conclude that expression of SRp20DRRM
significantly reduced the levels of poliovirus produced, and that
this protein may function as a dominant-negative in the cell.
Discussion
Overall these results provide important new insights into the
localization and functions of IRES trans-activating factors (ITAFs)
during poliovirus infection. Splicing factor SRp20 was found to
dramatically re-localize from the nucleus to the cytoplasm of the
cell during poliovirus infection. Although other RNA binding
proteins have been shown to re-localize to the cytoplasm of
poliovirus-infected cells [35,49,50,51,52,53,54], this is the first
time that a member of the SR family of proteins has been shown to
display an altered localization and accumulation in the cytoplasm
during poliovirus infection. The re-localization of SRp20 to the
cytoplasm of the infected cell, where the virus life cycle occurs, is
consistent with previous work from our lab showing the essential
role of SRp20 in poliovirus IRES-mediated translation [18].
It is not yet clear whether SRp20 is more rapidly exported from
the nucleus during poliovirus infection, whether its re-import from
the cytoplasm is prevented during infection, if both processes are
affected, and/or if other factors contribute to re-localization.
Previous studies have demonstrated that SC35, another nuclear
splicing factor, remains in the nucleus of poliovirus-infected cells at
3 hours post-infection, even though other import pathways are
disrupted [35,49]. Our findings for SRp20 localization during
poliovirus infection are in stark contrast to that of SC35 at 3 hours
post-infection; notably, SC35 is not a shuttling splicing factor. In
the case of the SR family of proteins, these factors utilize
Transportin-SR for nuclear import [46]. Because SC35 was found
in the nucleus at 3 hours post-infection, this may indicate that the
SR protein import pathway is intact during poliovirus infection
because SC35, translated in the cytoplasm during infection, is still
localized in the nucleus. It has also been demonstrated that some
components of the nuclear pore complex are targeted for
degradation during poliovirus infection, which likely affects
multiple import and export pathways [35,55]. This led to the
conclusion that disruption in nuclear import is a factor in the
cytoplasmic accumulation of some nuclear proteins (although
possibly not SR proteins), while export may or may not be
affected. Additional work has shown that nuclear export is also
affected, and that an overall increase in the permeability of the
nuclear envelope occurs during poliovirus infection, suggesting
that protein trafficking is affected in a bidirectional way [56].
Interestingly, not all nuclear proteins re-localize to the cytoplasm
of poliovirus-infected cells, and not all proteins that re-localize
during infection necessarily do so with the same kinetics or to the
same extent. For example, hnRNP C was found to re-localize to
the cytoplasm of poliovirus-infected cells, but not to readily-
detectable levels until 4 hours post-infection [35,50]. Therefore,
the specific cause of the re-localization of SRp20 during poliovirus
infection remains to be determined, as does the potential role of
other SR proteins (particularly other shuttling SR proteins) in
poliovirus IRES-dependent translation.
We predicted we would be able to visualize PCBP2 and SRp20
co-localizing during infection, and thus in close proximity to each
other in the cytoplasm of infected cells, because our lab has
previously identified the interaction of these two proteins in
extracts from poliovirus-infected cells via co-immunoprecipitation
assays [18]. Our imaging data of the co-localization of PCBP2 and
SRp20 corroborates our previous in vitro interaction data using
recombinant proteins and GST pull down assays, and illustrates
the close proximity of PCBP2 and SRp20 in the cytoplasm of
intact cells during poliovirus infection.
Using sucrose gradient fractionation of extracts from mock- or
poliovirus-infected cells, we detected both PCBP2 and SRp20 in
Figure 11. SRp20DRRM partial co-localization with PCBP2 in the cytoplasm of poliovirus-infected SK-N-SH cells. Cells were transfected
with SRp20DRRM and mock-infected (A) or infected with poliovirus for 3 hours (B) at an MOI of 25. At 3 hours post-infection, cells were fixed and
incubated with a PCBP2 monoclonal antibody, a secondary antibody conjugated to biotin, and streptavidin conjugated to Texas Red. Cells were
examined for co-localization of PCBP2 and SRp20DRRM (shown in the merged image in yellow and highlighted by white arrows) in the cytoplasm of
the cells using confocal microscopy; nuclei were identified by DAPI staining.
doi:10.1371/journal.ppat.1002127.g011
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PLoS Pathogens | www.plospathogens.org 15 July 2011 | Volume 7 | Issue 7 | e1002127Figure 12. Effect of SRp20DRRM expression on poliovirus yield. Cells were co-transfected with poliovirus cDNA and a plasmid expressing
either GFP alone, GFP-SRp20, or GFP-SRp20DRRM. Virus was harvested from the cells at 96 hours post-transfection and serially diluted. Dilutions of
virus were used to carry out plaque assays (B), and whole cell extracts were also generated to determine the levels of expression of the SRp20
proteins by Western blot using an antibody against SRp20 (A). In (A) lane 1, cells transfected with the plasmid expressing GFP; lane 2, expressing GFP-
SRp20; lane 3, expressing GFP-SRp20DRRM. Cells expressing the deletion mutant, GFP-SRp20DRRM, displayed a two-log decrease in poliovirus yield
(C). The observed decrease (,100 fold) was consistent across three separate experiments, although overall titers for the GFP control between
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detected in fractions containing 80S monosomes. The significance
of SRp20 co-sedimentation with 80S monosomes is not yet known,
although other SR proteins have been shown to co-sediment with
80S monosomes or polysomes for cap-dependent translation
[24,25,26]. The sedimentation of PCBP2 resembles, in part, the
sedimentation of a canonical translation initiation factor eIF2a.
Importantly, PABP co-sedimentation with polysomes in extracts
from mock-infected cells is consistent with its function in cap-
dependent translation, and validates our assay. The co-sedimen-
tation of SRp20 and PCBP2 with 40S ribosomal subunits in
extracts from poliovirus-infected cells is consistent with these
proteins functioning in translation initiation complex formation for
poliovirus IRES-mediated translation. It is possible that these
proteins are present in viral translation initiation complexes, and
are released from the assembled ribosome at or just after 60S
subunit-joining. The release of canonical translation factors from
cap-dependent translation initiation complexes is known to occur,
and these factors are recycled for subsequent rounds of initiation
[57]. SRp20 and PCBP2 are also found to co-sediment with 40S
subunits in extracts from mock-infected cells. This would suggest
that the virus is taking advantage of a yet undiscovered mechanism
already present in the cells, which then functions to initiate
translation of the viral RNA. Further fractionation and mass
spectrometry analysis of 40S gradient fractions will be required to
identify other factors involved in the formation of initiation
complexes for poliovirus translation, including those capable of
interacting with PCBP2 and/or SRp20.
RNA affinity assays showed that SRp20 is associated with
PCBP2 bound to poliovirus stem-loop IV in the 59 NCR of
genomic RNA. Previous work had defined the direct binding of
PCBP2 to poliovirus stem-loop IV [44,58]; importantly, SRp20
does not appear to bind stem-loop IV directly (unpublished
results). This suggests that SRp20 is associated with the viral RNA
via its interaction with PCBP2. This interaction may then function
to recruit the translation complex to the viral RNA either directly
or indirectly, through other protein-protein or protein-RNA
associations. Future studies will focus on identifying other factors
that affinity-purify with poliovirus RNA and/or interact with
SRp20 directly.
The RS domain of SRp20 can be highly phosphorylated, and its
phosphorylation is important for its functions in the cell (e.g.,
splicing and nuclear export, for review, see [23]). The phosphor-
ylation state of SRp20 when interacting with PCBP2 bound to
poliovirus stem-loop IV has not been completely defined. Western
blot analysis using an antibody that recognizes only the phosphor-
ylated forms of SR proteins (pan-SR hybridoma supernatant
mAb104, a gift from Dr. Roz Sandri-Goldin) suggested that little
of the SRp20 that co-purified with PCBP2 and poliovirus stem-loop
IV was phosphorylated (data not shown). In addition, co-
immunoprecipitation assays after alkaline phosphatase treatment
(or mock-treatment) of extracts from poliovirus-infected cells to
dephosphorylate proteins in the extracts indicated that only
unphosphorylated SRp20 interacts with PCBP2 in these extracts
(data not shown). These preliminary results suggest that the
unphosphorylated form of SRp20 is important for poliovirus
translation, although additional analyses will need to be carried
out to confirm this prediction.
Our experiments with a deleted form of SRp20 (SRp20DRRM)
demonstrated that its localization was similar to that of the wild
type protein: it was found mainly in the nucleus of mock-infected
cells and re-localized to the cytoplasm of poliovirus-infected cells.
Our findings are consistent with published data for the Drosophila
homologue of SRp20 (Rbp1), that even when lacking the RRM
domain still localized like the wild type protein in insect cells [48].
The nuclear localization of SRp20DRRM in mock-infected cells
was expected since the RS domain acts as a nuclear localization
signal for SR proteins. It was initially predicted that the deleted
form of SRp20 would in fact re-localize to the cytoplasm during
poliovirus-infection since the mutated protein still contains the
portion of the protein required for TAP interaction and export
[30], although we do not yet know the mechanism by which
SRp20 re-distributes to the cytoplasm of the cells during poliovirus
infection.
Co-localization of PCBP2 and SRp20DRRM suggests that these
two proteins are in close proximity in the cytoplasm of the cell
during infection. SRp20DRRM lacks one of its two defined
functional domains, thus we predicted that this truncated protein
would still interact with PCBP2 (since it contains the RS domain
required for PCBP2 interaction) but would result in a non-
functional interaction for poliovirus translation. Indeed, expression
of SRp20DRRM resulted in an approximate two-log decrease in
virus yield for poliovirus when compared to expression of wild type
SRp20 or vector alone. These results and the co-localization data
suggest that SRp20DRRM can still interact with PCBP2, but in a
non-functional complex for poliovirus infection. We propose that
SRp20DRRM acts as a dominant negative protein and effectively
sequesters PCBP2 from functional translation complexes, leading to
a decrease in virus yield. We do not yet know the mechanism of the
dominant negative function of SRp20DRRM, although ongoing
studies will elucidate whether SRp20DRRM can interact with
PCBP2 bound to the viral RNA, determine the kinetics of the
poliovirusgrowthdefectobservedwithexpressionofSRp20DRRM,
and investigate the specific effect of SRp20DRRM expression on
viral translation.
Overall these studies have provided new evidence for the
importance of PCBP2-SRp20 interaction in intact cells during
poliovirus infection and suggest a model by which PCBP2, bound
to the viral RNA, interacts with SRp20 and functions to recruit the
translation initiation complex to the viral RNA. The localization of
SRp20 changes dramatically during poliovirus infection, and its
accumulation in the cytoplasm would allow for its continued
availability for poliovirus translation. In addition, when SRp20
lacks one of its two defined functional domains its expression
results in a decrease in virus yield for poliovirus. This finding
further underscores the significance of SRp20 for poliovirus
infection. On a broader scale, this work provides insights into
potential mechanisms of ribosome recruitment for picornavirus
IRES-mediated translation initiation, and how non-canonical
factors play a role in bridging the translation machinery to the
RNA.
Supporting Information
Video S1 Subcellular 3-D analysis of PCBP2-SRp20 co-
localization. Z-stack analysis was performed for some of the
images collected for the co-localization studies (data not shown). Z-
stacks were rendered into three dimensions using the Volocity
Image Analysis Software (PerkinElmer) to generate QuickTime
movies of the cells in rotation to further investigate the subcellular
experiments ranged from ,10
5 to ,10
7 (likely due to the variability of DNA transfection efficiency). Plaque assays to determine poliovirus titers were
performed in triplicate.
doi:10.1371/journal.ppat.1002127.g012
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displayed in green, PCBP2 is shown in red, and areas of yellow
in the cytoplasm indicate co-localization.
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